GALNT14 genotype, α-fetoprotein and therapeutic side effects predict post-chemotherapy survival in patients with advanced hepatocellular carcinoma

In addition to targeted agents, chemotherapy is currently considered to be a treatment option for patients with advanced hepatocellular carcinoma (HCC); however, it is associated with severe side effects that may limit its clinical use. UDP-N-acetyl-α-D-galactosamine:polypeptide N-acetyl-galactosami...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: LIN, WEY-RAN, HSU, CHAO-WEI, CHEN, YI-CHENG, CHANG, MING-LING, LIANG, KUNG-HAO, HUANG, YA-HUI, YEH, CHAU-TING
Format: Artigo
Langue:Inglês
Publié: D.A. Spandidos 2014
Sujets:
Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4051573/
https://ncbi.nlm.nih.gov/pubmed/24940508
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2014.294
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires